Maia BiotechnologyMAIA
13F holders, Q2 2026 (June 30)At the end of Q2 2026, 36 institutions reported holding Maia Biotechnology Inc. (MAIA) in their 13F filings, up 3 from Q1 2026. 13 opened new positions and 10 sold out. The largest holders were Solas Capital Management, LLC ($4.4M), Alyeska Investment Group, L.P. ($3.6M) and Vanguard Capital Management LLC ($3.5M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Maia Biotechnology Inc.
- CUSIP
- 552641102
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 13 | $1.2M |
| Exits | 10 | $274K |
All 13F filers, Q1 2026 → Q2 2026: 1,986,783 shares bought and 1,614,670 shares sold, net +372,113 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 36 holders
| Solas Capital Management, LLC | 2.34% | Reduce -29.5% | 3,030,845 | $4.4M |
| Alyeska Investment Group, L.P. | 0.01% | No change | 2,500,000 | $3.6M |
| Vanguard Capital Management LLC | 0.00% | Add +16.4% | 2,413,270 | $3.5M |
| 683 Capital Management, LLC | 0.15% | No change | 1,066,666 | $1.5M |
| Centric Wealth Management | 0.17% | No change | 796,723 | $1.1M |
| Cable Car Capital, LP | 0.02% | Reduce -20.6% | 514,583 | $741K |
| Geode Capital Management, LLC | 0.00% | Add +39.9% | 504,380 | $727K |
| Bleichroeder LP | 0.13% | No change | 500,000 | $720K |
| Renaissance Technologies | 0.00% | New | 415,700 | $599K |
| BlackRock, Inc. | 0.00% | Add +214.9% | 403,011 | $580K |
| Vanguard Fiduciary Trust Co. | 0.00% | Add +68.9% | 336,688 | $485K |
| State Street Corp. | 0.00% | Add +45.2% | 201,750 | $291K |
| Bleakley Financial Group, LLC | 0.00% | New | 181,623 | $262K |
| Northern Trust Corp. | 0.00% | Add +138.2% | 125,171 | $180K |
| Morgan Stanley | 0.00% | Add +650.5% | 104,017 | $150K |
| Bridgeway Capital Management, LLC | 0.00% | Add +111.1% | 76,000 | $109K |
| Two Sigma Investments, LP | 0.00% | New | 50,383 | $73K |
| Envestnet Asset Management Inc. | 0.00% | New | 44,347 | $64K |
| Susquehanna International Group, LLP | 0.00% | New | 35,223 | $51K |
| PVG Asset Management Corp. | 0.03% | No change | 34,135 | $49K |
| UBS Group AG | 0.00% | Reduce -35.6% | 33,435 | $48K |
| Citadel Advisors | 0.00% | New | 24,890 | $36K |
| Cetera Investment Advisers | 0.00% | New | 22,748 | $33K |
| Lazari Capital Management, Inc. | 0.01% | New | 21,750 | $31K |
| Atria Investments, Inc | 0.00% | New | 21,100 | $30K |
| Centerpoint Advisory Group | 0.01% | No change | 15,730 | $23K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | No change | 14,800 | $21K |
| Vanguard Global Advisers, LLC | 0.00% | No change | 11,401 | $16K |
| Osaic Holdings, Inc. | 0.00% | No change | 8,334 | $12K |
| Daytona Street Capital LLC | 0.01% | No change | 7,500 | $11K |
| Barclays PLC | 0.00% | New | 4,152 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 3,208 | $5K |
| Jones Financial Companies LLLP | 0.00% | No change | 228 | $321 |
| Caitong International Asset Management Co., Ltd | 0.00% | New | 210 | $302 |
| Wells Fargo & Company | 0.00% | New | 200 | $288 |
| Citigroup Inc. | 0.00% | Add +581.8% | 150 | $216 |
"% of holder's portfolio" is MAIA's weight in each manager's 13F, not the share of Maia Biotechnology Inc. the manager owns.